These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37294284)

  • 1. Aptamer Reduces Aggregation of Mutant Huntingtin and Rescues Proteostasis Network in Non-Neuronal and Neuronal Cells.
    Jain S; Roy I
    ACS Chem Neurosci; 2023 Jun; 14(12):2385-2395. PubMed ID: 37294284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleic Acid Therapeutics in Huntington's Disease.
    Singh K; Roy I
    Recent Pat Biotechnol; 2019; 13(3):187-206. PubMed ID: 30747088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the proteostasis network in Huntington's disease.
    Soares TR; Reis SD; Pinho BR; Duchen MR; Oliveira JMA
    Ageing Res Rev; 2019 Jan; 49():92-103. PubMed ID: 30502498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteostasis of Huntingtin in Health and Disease.
    Koyuncu S; Fatima A; Gutierrez-Garcia R; Vilchez D
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28753941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herp Promotes Degradation of Mutant Huntingtin: Involvement of the Proteasome and Molecular Chaperones.
    Luo H; Cao L; Liang X; Du A; Peng T; Li H
    Mol Neurobiol; 2018 Oct; 55(10):7652-7668. PubMed ID: 29430620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential roles for DNAJ isoforms in HTT-polyQ and FUS aggregation modulation revealed by chaperone screens.
    Rozales K; Younis A; Saida N; Meller A; Goldman H; Kellerman L; Heinrich R; Berlin S; Shalgi R
    Nat Commun; 2022 Jan; 13(1):516. PubMed ID: 35082301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric activation of Hsp70 reduces mutant huntingtin levels, the clustering of N-terminal fragments, and their nuclear accumulation.
    Pinho BR; Almeida LM; Duchen MR; Oliveira JMA
    Life Sci; 2021 Nov; 285():120009. PubMed ID: 34600937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Withaferin A Induces Heat Shock Response and Ameliorates Disease Progression in a Mouse Model of Huntington's Disease.
    Joshi T; Kumar V; Kaznacheyeva EV; Jana NR
    Mol Neurobiol; 2021 Aug; 58(8):3992-4006. PubMed ID: 33904021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ubiquitin ligase UBR5 suppresses proteostasis collapse in pluripotent stem cells from Huntington's disease patients.
    Koyuncu S; Saez I; Lee HJ; Gutierrez-Garcia R; Pokrzywa W; Fatima A; Hoppe T; Vilchez D
    Nat Commun; 2018 Jul; 9(1):2886. PubMed ID: 30038412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing aptamers which respond to intracellular oxidative stress and inhibit aggregation of mutant huntingtin.
    Patel KA; Kolluri T; Jain S; Roy I
    Free Radic Biol Med; 2018 May; 120():311-316. PubMed ID: 29609019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidation of Site-Specific Ubiquitination on Chaperones in Response to Mutant Huntingtin.
    Panda P; Sarohi V; Basak T; Kasturi P
    Cell Mol Neurobiol; 2023 Dec; 44(1):3. PubMed ID: 38102300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-chaperones DNAJA1 and DNAJB6 are critical for regulation of polyglutamine aggregation.
    Rodríguez-González C; Lin S; Arkan S; Hansen C
    Sci Rep; 2020 May; 10(1):8130. PubMed ID: 32424160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TBK1 phosphorylates mutant Huntingtin and suppresses its aggregation and toxicity in Huntington's disease models.
    Hegde RN; Chiki A; Petricca L; Martufi P; Arbez N; Mouchiroud L; Auwerx J; Landles C; Bates GP; Singh-Bains MK; Dragunow M; Curtis MA; Faull RL; Ross CA; Caricasole A; Lashuel HA
    EMBO J; 2020 Sep; 39(17):e104671. PubMed ID: 32757223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive astrocytes promote proteostasis in Huntington's disease through the JAK2-STAT3 pathway.
    Abjean L; Ben Haim L; Riquelme-Perez M; Gipchtein P; Derbois C; Palomares MA; Petit F; Hérard AS; Gaillard MC; Guillermier M; Gaudin-Guérif M; Aurégan G; Sagar N; Héry C; Dufour N; Robil N; Kabani M; Melki R; De la Grange P; Bemelmans AP; Bonvento G; Deleuze JF; Hantraye P; Flament J; Bonnet E; Brohard S; Olaso R; Brouillet E; Carrillo-de Sauvage MA; Escartin C
    Brain; 2023 Jan; 146(1):149-166. PubMed ID: 35298632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
    Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
    Elife; 2021 Apr; 10():. PubMed ID: 33871358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Aggregation of Mutant Huntingtin by Nucleic Acid Aptamers In Vitro and in a Yeast Model of Huntington's Disease.
    Chaudhary RK; Patel KA; Patel MK; Joshi RH; Roy I
    Mol Ther; 2015 Dec; 23(12):1912-26. PubMed ID: 26310631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-27a reduces mutant hutingtin aggregation in an in vitro model of Huntington's disease.
    Ban JJ; Chung JY; Lee M; Im W; Kim M
    Biochem Biophys Res Commun; 2017 Jun; 488(2):316-321. PubMed ID: 28495533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of huntingtin at residue T3 is decreased in Huntington's disease and modulates mutant huntingtin protein conformation.
    Cariulo C; Azzollini L; Verani M; Martufi P; Boggio R; Chiki A; Deguire SM; Cherubini M; Gines S; Marsh JL; Conforti P; Cattaneo E; Santimone I; Squitieri F; Lashuel HA; Petricca L; Caricasole A
    Proc Natl Acad Sci U S A; 2017 Dec; 114(50):E10809-E10818. PubMed ID: 29162692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant huntingtin disrupts mitochondrial proteostasis by interacting with TIM23.
    Yablonska S; Ganesan V; Ferrando LM; Kim J; Pyzel A; Baranova OV; Khattar NK; Larkin TM; Baranov SV; Chen N; Strohlein CE; Stevens DA; Wang X; Chang YF; Schurdak ME; Carlisle DL; Minden JS; Friedlander RM
    Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16593-16602. PubMed ID: 31346086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of protein aggregation by chaperone modification of high molecular weight complexes.
    Labbadia J; Novoselov SS; Bett JS; Weiss A; Paganetti P; Bates GP; Cheetham ME
    Brain; 2012 Apr; 135(Pt 4):1180-96. PubMed ID: 22396390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.